Lumit™ Technology can also be used to detect antibodies. The Lumit™ SARS-CoV-2 Immunoassay uses a fragment of the SARS-CoV-2 spike protein receptor binding domain (RBD) labeled with SmBiT and LgBiT. When the labeled viral protein fragments are incubated with a sample containing SARS-CoV-2 antibodies, they bind to the antibody, bringing the SmBiT and LgBiT subunits together to generate a luminescence signal.
The Lumit™ Dx SARS-CoV-2 Immunoassay is available as a diagnostic assay in the United States. The assay is also ideal for research applications such as population surveillance, epidemiological studies and vaccine research.
Antibody labeling kit and detection reagents to build your own immunoassays.
Kits to detect specific targets including cytokines, insulin, glucagon, neonatal fc receptor binding, and phosphorylation activity.
The Lumit™ Dx SARS-CoV-2 Immunoassay detects SARS-CoV-2 antibodies and is suitable for use in diagnostic and research applications.
Consult with our team to develop your own Lumit™ application.
Contact us to discuss your assay development needs.
Optimize Your Lumit™ Immunoassay Workflow With Support From Our Automation Experts
Our Field Support Specialists are experts in major liquid handler types, including the Promega Maxprep™ System, Hamilton Microlab STAR® series, Tecan Freedom EVO® and Fluent® series, Eppendorf epMotion® and Beckman Biomek® series. We offer prewritten and customized scripts and in-lab/remote assistance. Let us help optimize your current workflow or discuss automation solutions to fit your lab’s needs.
- Hall M.P., Unch J., Binkowski B.F., et al. (2012) Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol. 7(11), 1848-1857. doi:10.1021/cb3002478
- Dixon A.S., Schwinn M.K, Hall M.P., et al. (2016) NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells. ACS Chem Biol. 11(2), 400-408. doi:10.1021/acschembio.5b00753
- Hwang B.B., Engel L., Goueli S.A., Zegzouti H. (2020) A homogeneous bioluminescent immunoassay to probe cellular signaling pathway regulation. Commun Biol. 3:8. doi:10.1038/s42003-019-0723-9